by Team Small News | Nov 12, 2025 | Glenmark, Pharma, Zydus
Zydus Lifesciences and Glenmark Pharmaceuticals have both received approvals from China’s National Medical Products Administration (NMPA) for their respective products. Zydus Lifesciences has been granted approval for Venlafaxine Extended-Release (ER) Capsules,...
by Team Small News | Nov 9, 2025 | Pharma, Zydus
Zydus Lifesciences Limited, an Indian pharmaceutical company, has received tentative approval from the United States Food and Drug Administration (USFDA) for its Olaparib Tablets, 100 mg and 150 mg. This medication is used to treat certain types of ovarian, breast,...
by Team Small News | Nov 4, 2025 | Pharma, Zydus
Zydus Lifesciences, a prominent pharmaceutical company, is facing a significant demand of Rs 74.23 crore from the Goods and Services Tax (GST) authorities. The company plans to challenge this order, indicating a potential dispute over the tax assessment. The GST...
by Team Small News | Oct 30, 2025 | Pharma, Zydus
Zydus Lifesciences, a pharmaceutical company, has been instructed to revise a post-marketing surveillance (PMS) study for its Tofacitinib ER (extended-release) tablets. The company had submitted the study protocol to the regulatory authorities, but it appears that the...
by Team Small News | Oct 13, 2025 | Pharma, Zydus
Dr. Reddy’s and Zydus Lifesciences, two major Indian pharmaceutical companies, have initiated recalls of certain medicines in the US due to quality issues. The recalls were voluntarily undertaken by the companies by the US Food and Drug Administration (US FDA)....
by Team Small News | Oct 12, 2025 | Pharma, Zydus
Dr. Reddy’s Laboratories and Zydus Lifesciences, two major pharmaceutical companies, are recalling certain products in the US due to manufacturing issues. According to the US Food and Drug Administration (USFDA), Dr. Reddy’s Laboratories is recalling 571...